New Key Statistics Module, Z-Score and F-Score
NAS:LUMO Key Ratios
| Market Cap $ M | 20.45 |
| Enterprise Value $ M | -1.40 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.17 |
| Price/Sales | 7.51 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2.00 |
| EPS (TTM) $ | -5.48 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 20.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.03 |
| EV-to-EBITDA | 0.03 |
| PEG | -- |
| Shares Outstanding M | 8.12 |
| Net Margin (%) | -2,007.00 |
| Operating Margin % | -2,142.42 |
| Pre-tax Margin (%) | -2,008.30 |
| Quick Ratio | 6.24 |
| Current Ratio | 6.24 |
| ROA % (ttm) | -94.00 |
| ROE % (ttm) | -126.05 |
| ROIC % (ttm) | -1,505.81 |
| Dividend Yield % | -- |
| Altman Z-Score | -11.54 |
LUMO Number of Guru Trades
LUMO Volume of Guru Trades
Gurus Latest Trades with NAS:LUMO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LUMO is held by these investors
Total 1
Lumos Pharma Inc Insider Transactions
No Available Data
News about NAS:LUMO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers